|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Acetazolamide#How Supplied]] |
| {{Acetazolamide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==How Supplied Storage and Handling==
| |
| | |
| HOW SUPPLIED:
| |
| | |
| DIAMOX® SEQUELS® (Acetazolamide Extended-Release Capsules) are available as 500 mg:
| |
| | |
| Orange opaque cap and orange opaque body filled with white to off-white pellets. Imprinted in black ink, DIAMOX 754.
| |
| | |
| Available in bottles of:
| |
| | |
| {|
| |
| |[[File:acetazolamide02.jpg|thumb|800px]]
| |
| |}
| |
| Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
| |
| | |
| DURAMED PHARMACEUTICALS, INC.
| |
| | |
| Subsidiary of Barr Pharmaceuticals, Inc.
| |
| | |
| Pomona, New York 10970
| |
| | |
| Revised JULY 2008
| |
| | |
| BR-754<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e47451-2bc8-496e-88ad-c10002ee8e22 | publisher = | date = | accessdate = 25 February 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{Anticonvulsants}}
| |
| {{Antiglaucoma preparations and miotics}}
| |
| {{Diuretics}}
| |
| | |
| [[Category:Carbonic anhydrase inhibitors]]
| |
| [[Category:Mountaineering and health]]
| |
| [[Category:Anticonvulsants]]
| |
| [[Category:Sulfonamides]]
| |
| [[Category:World Health Organization essential medicines]]
| |
| [[Category:Thiadiazoles]]
| |
| [[Category:Amides]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |